The Thesis
RSI Snap-Back is a mean-reversion play on the Mag-7 (AAPL, MSFT, NVDA, GOOGL, AMZN, META, TSLA). The premise is clean and well-worn: large-cap tech names overshoot on short-term momentum extremes and then revert. The strategy buys the most oversold names as RSI drops below 35, exits into overbought territory above RSI 70, and rotates to hold a tight four-name book. That hard four-slot cap is the risk-management backbone — it forces concentration discipline and limits how many correlated drawdowns can stack up at once.
It's an intuitive, testable idea. The open question is whether reversion in a persistently trending megacap complex is a durable edge or a coin flip dressed up as a signal.
Backtest Performance
Over 451 days and 37 trades, the backtest returned 20.95% (final equity $12,095 on a $10,000 base), an 11.21% CAGR, and a 66.67% win rate. Two out of three trades landing green is genuinely encouraging for a reversion system, and costs were negligible — $37 in total fees, zero FX drag.
The caveats sit right next to the wins. The Sharpe of 0.61 is modest, meaning the return came with meaningful volatility rather than smooth compounding. More pointedly, the maximum drawdown of 23.73% is larger than the total return itself — an investor could have been underwater by nearly a quarter of capital before the strategy dug out. Turnover of 773% also flags a high-churn approach: the edge has to clear a lot of round-trips to stay ahead, and any slippage or execution friction not modelled here erodes it fast.
Recent Activity
Here's the part worth watching. Across six consecutive scheduled runs from July 20 through July 27, the strategy executed zero trades and rejected zero — cash and total equity both parked at exactly $10,000 the entire week. In live mode, RSI Snap-Back is currently doing nothing.
That isn't necessarily a fault. A reversion system with no signal is supposed to stay in cash rather than force a trade, and none of the seven names apparently breached the RSI < 35 entry threshold. But it does mean the live track record is still a blank slate — the 20.95% figure is a backtest result, not realized live performance.
Strengths and Risks
Strengths: a coherent, disciplined rule set; a healthy backtested win rate; tight cost control; and a concentration cap that enforces restraint.
Risks: the drawdown rivals the return, the Sharpe is unremarkable, and turnover is high. Most importantly, the validation field is null — there is no out-of-sample or walk-forward check on record. A 20.95% backtest with no validation is a hypothesis, not a proven edge, and reversion strategies are especially prone to curve-fitting on a lucky in-sample window.
Verdict
RSI Snap-Back is a sensibly built idea with a promising in-sample result and honest, disciplined mechanics. Before treating that return as real, it needs two things: a validation pass to confirm the edge survives out of sample, and enough live runs to show the backtest wasn't a mirage. For now, a patient strategy waiting for its setup — with the receipts still pending.